Experience

Operations, technology, quality, and digital transformation across biotechnology organizations.

My executive experience spans biotechnology strategy, CDMO operations, quality systems, biologics manufacturing, commercial execution, board partnership, and digital transformation. The through-line is cross-functional leadership: connecting the parts of an organization that must work together for science to become reliable execution.

January 2026–Present

Chief Technology Officer

Cell Culture Company (formerly Biovest International) | Minneapolis, MN

Lead enterprise technology strategy and digital transformation for a biotechnology CDMO, translating business priorities into practical systems that improve how quality, operations, customer support, commercial activities, and administrative functions work together.

  • Develop technology roadmap across quality, operations, customer support, commercial workflows, and administrative systems.
  • Lead practical AI and automation initiatives that convert institutional knowledge and recurring workflows into more scalable business processes.
  • Establish governance for AI adoption, data use, vendor selection, implementation risk, and sustainable system ownership.
  • Partner with executive leadership and the Board of Directors on technology investments, operating priorities, and long-term organizational strategy.
October 2019–January 2026

Chief Executive Officer

Cell Culture Company (formerly Biovest International) | Minneapolis, MN

Led corporate strategy, operations, quality, manufacturing, commercial activities, customer relationships, and financial performance for a biotechnology CDMO supporting therapeutic and diagnostic manufacturing.

  • Directed enterprise priorities across quality, manufacturing, process development, customer relationships, commercial activities, and administrative operations.
  • Led relocation of headquarters and GMP manufacturing facilities while maintaining continuity of customer work.
  • Maintained business continuity and regulatory compliance through pandemic disruption and subsequent shifts in customer demand.
  • Partnered with the Board of Directors and ownership on strategic planning, business risk, resource allocation, capital priorities, and long-term operating decisions.
  • Reshaped organizational structure, leadership responsibilities, and operating processes to improve accountability, decision-making, and cross-functional execution.
  • Maintained executive oversight of cGMP and ISO 9001 quality-system effectiveness, audit readiness, management review, and customer/regulatory expectations.
Earlier leadership

Operations, Quality, and Scientific Leadership

Cell Culture Company / Biovest International | Pharmasan Labs | University of Toledo Health Science Campus

Built the cross-functional foundation that later informed executive leadership, including CDMO operations, ISO 9001 certification, cGMP quality systems, regulated laboratory operations, clinical laboratory work, immunological assay development, and translational immunology research.

Selected foundation: Vice President of Operations, Vice President of Quality, Progressive Quality Leadership, Vaccine CMC Quality Control Senior Scientist, Pharmasan Labs immunology roles, and Ph.D./postdoctoral research.